Abstract.
Valproic acid (VPA) is a short-chain branched fatty with anti-inflammatory, neuro-protective and axon-remodeling effects. We investigated the effects of VPA in rats in which experimental autoimmune neuritis (EAN) had been induced (EAN rats). VPA (300 mg/kg, intraperitoneally) administration to EAN rats once daily immediately following immunization significantly suppressed mRNA levels of interferon-γ, tumor necrosis factor-α, interleukin (IL)-1β, IL-4, IL-6 and IL-17 in the lymph nodes of EAN rats. In peripheral blood and sciatic nerves of EAN rats, Foxp3+ cells were increased but IL-17+ cells were decreased during VPA treatment. Furthermore, suppressive and therapeutic treatment with VPA greatly attenuated both accumulation of macrophages, T cells and B cells, and demyelination in sciatic nerves, and greatly reduced the severity and duration of EAN. In summary, our data demonstrated that VPA could effectively suppress inflammation in EAN, suggesting that VPA could be a potent candidate for treatment of autoimmune neuropathies.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Received 25 August 2008; received after revision 23 September 2008; accepted 8 October 2008
Z. Zhang, Z. Y. Zhang: These authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zhang, Z., Zhang, Z.Y., Fauser, U. et al. Valproic acid attenuates inflammation in experimental autoimmune neuritis. Cell. Mol. Life Sci. 65, 4055 (2008). https://doi.org/10.1007/s00018-008-8521-4
Published:
DOI: https://doi.org/10.1007/s00018-008-8521-4